Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Bio-Protocol|June 17, 2026
A Reliable Method for Thawing Primary AML and CMML Mononuclear Cells to Preserve Viability and FunctionKelly Lim, Verity Saunders, Monika Kutyna, et al.Blood|July 17, 2010
The poor response to imatinib observed in CML patients with low OCT-1 activity is not attributable to lower uptake of imatinib into their CD34+ cellsJane R Engler, Amity Frede, Verity Saunders, et al.Blood|June 16, 2005
In vitro sensitivity to imatinib-induced inhibition of ABL kinase activity is predictive of molecular response in patients with de novo CMLDeborah White, Verity Saunders, A Bruce Lyons, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2007
Measurement of in vivo BCR-ABL kinase inhibition to monitor imatinib-induced target blockade and predict response in chronic myeloid leukemiaDeborah White, Verity Saunders, Andrew Grigg, et al.Anti-Cancer Drugs|February 15, 2021
Simvastatin enhances the efficacy of nilotinib in chronic myeloid leukaemia by post-translational modification and drug transporter modulationKartini Asari, Wen Tian Sun, Ze Hui Kok, et al.Blood Neoplasia|June 2, 2025
CD302 predicts achievement of deep molecular response in patients with chronic myeloid leukemia treated with imatinibChung Hoow Kok, Yazad Irani, Jade Clarson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Dasatinib cellular uptake and efflux in chronic myeloid leukemia cells: therapeutic implicationsDevendra K Hiwase, Verity Saunders, Duncan Hewett, et al.The Journal of Molecular Diagnostics : JMD|October 12, 2025
Enhanced Detection of Splice-Altering Variants in Hematologic Malignancies Using Targeted RNA-Sequencing DataMuneeza Maqsood, John Toubia, Carol Wadham, et al.The Journal of Molecular Diagnostics : JMD|May 13, 2022
RNA-Based Targeted Gene Sequencing Improves the Diagnostic Yield of Mutant Detection in Chronic Myeloid LeukemiaNaranie Shanmuganathan, Carol Wadham, Daniel Thomson, et al.Haematologica|March 23, 2023
Impact of additional genetic abnormalities at diagnosis of chronic myeloid leukemia for first-line imatinib-treated patients receiving proactive treatment interventionNaranie Shanmuganathan, Carol Wadham, NurHezrin Shahrin, et al.Pageof 1